ANUH PHARMA H1 FY27 ; TARGETS 15-20% ANNUAL GROWTH, PAT UP 42.25% YOY

H1 FY27 OPERATING REVENUE ₹379.05 CR, UP 1.80% YOY; EBITDA ₹36.92 CR, UP 39.11% YOY AT 9.74% MARGIN VS 7.13% LY; PAT ₹22.64 CR, UP 42.25% YOY Q2 FY27 REVENUE ₹185.24 CR, DOWN 4.42% QOQ; PAT ₹11.21 CR, DOWN 1.85% QOQ; NEW TARAPUR F-10 UNIT COMMISSIONED WITH 575 MTPA CAPACITY TAKING TOTAL TO 2,975 MTPA

Anuh Pharma Ltd

Open attachment

← Back to feed